Contract development and manufacturing organizations are capturing an increasing share of pharmaceutical production as drug companies focus on R&D and outsource manufacturing to specialized partners.
Market Intelligence
Contract development and manufacturing organizations are capturing an increasing share of pharmaceutical production as drug companies focus on R&D and outsource manufacturing to specialized partners.
Strategic Implications for IKON Group
IKON Group Investments actively incorporates this market intelligence into our investment evaluation and portfolio management processes. Our team of experienced investment professionals monitors developments across all our target sectors, leveraging insights to make better-informed decisions and create more value in our portfolio companies.
Portfolio Company Application
The insights discussed in this analysis directly inform how IKON Group works with our portfolio companies in healthcare, aerospace, biotechnology, real estate, energy, technology, and consumer sectors.